Nova Mentis

Nova Is The First Biotech Company To Achieve Psilocybin Orphan Drug Designation In Both The United States And European Union.

Nova mentis pharma reaching new heights for more patients. Ever wondered why it seems the big fish are eating the small fish? Nova mentis life science corp.

About Nova Mentis Life Science Corp.

Nova mentis what we think, we become. corp. Nova is the first biotech company to achieve psilocybin orphan drug designation in both the united states and european union. She is a tedx speaker and has received awards for her work presented at national and international conferences.

Nova Mentis Life Science Corp.

Nmlsf) (nova or the company), a biotechnology company and global. Mohammadi obtained her phd in biological physics from the donnelly. Nova mentis life science corp.

Our Focused Strategy Is To Develop Medicines That Limit Toxicities, Off Target Side Effects And Improve Our Patients’ Quality Of Life.

Nova mentis and mycrodose therapeutics have teamed up to test whether psychedelic treatments, such as nova’s psilocybin — a potential behavioral therapy for fragile x syndrome — can be delivered via the skin using mycrodose’s transdermal technology. About nova mentis life science corp. Nova mentis life science corp.

Why The Land Of Opportunity Seems To Be Growing Smaller?

Nova mentis life science corp. Jan 27, 2022 nova mentis study confirms oral microdose psilocybin treatment of autism. Nova is the first biotech company to achieve psilocybin orphan drug designation in both the united states and european union.